1. Project Name：Workshop for cephalothin category material medicine (synthesizingJing Gongbao, a kind of material medicine on the last step)
2. Undertaking Units: Nanjing Xian Sheng Dong Yuan Pharmaceutical Company Ltd.
3. Major Contents of the Project
Antibiotic of cephalothin category is a kind of antibiotic which has developed most rapidly since 1970 and has the most variety in the market. The raw material medicine declared for approval in the company, which reaches a number of 109, accounting for 1/3 of the total, has a promising market prospects. Cephalothin propylene material, cephalothin pivoxil material, Biapenem material of the company has declared for clinic and will obtain their new medicine certifications and manufacturing approval. Therefore, the company will become the first one who makes Biapenem come into domestic market, and the second in global market next to Japanese original research and development factory. Material medicine is supposed to reach a yield of 30 ton per year, and its total sale amount can reach ￥55.03 million from 2007 to 2011.
4. Prospective gross investment
(1) Gross investment capital of the project involves ￥47 million.
(2) Construction periods of the project are supposed to be two years.
(3) Prospective return rate of the project is 18%.
(4) Prospective investment reclaiming periods of the project are 3.03 years.
5. Advice for introduction cooperation
Technological cooperation or investment cooperation
6. Linkman: Ge Zongming
Corresponding address: Xinglong Road No.8, Economic Development Area, Pukou, Nanjing
Mail Code: 211800 
Tel: 025-58286999－777
Fax: 025-58285555
E-mail: gezongming@simcereoa.com